Cyclophosphamide
7 NDCs across 4 manufacturers|7 Generic,0 Brand
Cyclophosphamide is used to treat anemia, hemolytic, autoimmune, breast neoplasms, burkitt lymphoma, endometrial neoplasms, granulomatosis with polyangiitis and hemosiderosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Feb 16, 1982. FDA's Orange Book lists 12 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $2 million on Cyclophosphamide across 5,947 claims for 1,739 beneficiaries.
Cyclophosphamide is available as 7 NDCs from 4 manufacturers (7 generic, 0 brand), with NADAC prices from $1.12 to $227.72 per EA — the most expensive product costs about 203× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
7
7G / 0B
Manufacturers
4
competing in market
Price Spread
$1.12 – $227.72
per EA
7d Activity
avg +2.4% WoW · of 7 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
4 manufacturers producing CYCLOPHOSPHAMIDE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
CYCLOPHOSPHAMIDE 500 MG VIAL | $227.7200 per EA | — |
CYCLOPHOSPHAMIDE 50 MG CAPSULE | $1.5553 per EA | +2.40% |
CYCLOPHOSPHAMIDE 50 MG CAPSULE | $1.5553 per EA | +2.40% |
CYCLOPHOSPHAMIDE 50 MG CAPSULE | $1.5553 per EA | +2.40% |
CYCLOPHOSPHAMIDE 25 MG CAPSULE | $1.1212 per EA | — |
CYCLOPHOSPHAMIDE 25 MG CAPSULE | $1.1212 per EA | — |
CYCLOPHOSPHAMIDE 25 MG CAPSULE | $1.1212 per EA | — |
Frequently Asked Questions
What is Cyclophosphamide used to treat?
Cyclophosphamide is used to treat anemia, hemolytic, autoimmune, breast neoplasms, burkitt lymphoma, endometrial neoplasms, granulomatosis with polyangiitis and hemosiderosis, per the National Library of Medicine's MED-RT classification.
When did Cyclophosphamide become available as a generic?
FDA approved the first generic Cyclophosphamide (ANDA) on Feb 16, 1982. The Orange Book currently lists 12 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Cyclophosphamide?
In 2024, Medicare Part D spent $2 million on Cyclophosphamide across 5,947 claims for 1,739 beneficiaries.
How many Cyclophosphamide products are on the market?
The Cyclophosphamide drug market contains 7 NDCs from 4 manufacturers — 7 generic and 0 brand products.
What is the price range for Cyclophosphamide?
NADAC reference prices for Cyclophosphamide range from $1.1212 to $227.7200 per EA — the most expensive product costs about 203× the cheapest.
Which manufacturers make Cyclophosphamide?
4 manufacturers list Cyclophosphamide in NADAC. Ranked by number of NDCs, the largest are Alembic Pharmaceuticals Inc. (2), Cipla USA Inc. (2), Hikma Pharmaceuticals USA Inc. (2), Baxter Healthcare Corporation (1).
How has the price of Cyclophosphamide changed recently?
Over the past 7 days, 3 Cyclophosphamide NDCs rose and 0 fell, with a market-wide average change of +2.4%.